Uni-Bio Science Group Limited Announces 2022 Annual Results
- Written by Viw Magazine
Record High Turnover of HK$440.3 Million and HK$38.5 Million Profit Achieved
Expanding Portfolio with New Drug Innovations and Strategic R&D Partnerships
HONG KONG SAR - EQS Newswire - 27 March 2023 - A fully integrated biopharmaceutical company – Uni-Bio Science Group Limited ("Uni-Bio Science", together with its subsidiaries referred to as the "Group", stock code: 0690.HK), is pleased to announce its annual results for the year ended 31 December 2022 (the "Year").
Expanding Portfolio with New Drug Innovations and Strategic R&D Partnerships
HONG KONG SAR - EQS Newswire - 27 March 2023 - A fully integrated biopharmaceutical company – Uni-Bio Science Group Limited ("Uni-Bio Science", together with its subsidiaries referred to as the "Group", stock code: 0690.HK), is pleased to announce its annual results for the year ended 31 December 2022 (the "Year").
